A new dawn: Managing IP’s China Special Focus 2023 launched

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

A new dawn: Managing IP’s China Special Focus 2023 launched

terrace-4440132.jpg

As China wakes up to a raft of new laws and innovations, Managing IP partnered with the country’s leading IP experts to meet the sunrise

With the 2021 amendment to China’s Patent Law in full force, and with rights holders adopting increasingly aggressive damages claims in China’s courts, there is much for businesses and IP professionals to keep abreast of.

As such, authors from Chang Tsi & Partners analyse the new Patent Law, as the country strives for a competitive IP protection platform on the global stage. Chinese courts are playing an active role in shaping global IP governance rules by issuing anti-suit injunctions and asserting their jurisdiction over SEP's global rate, further cementing China's position as a preferred destination for international IP litigation.

In light of this dynamic IP litigation landscape, experts from Wanhuida outline the various defence mechanisms patentees have at their disposal when facing infringement accusations in China.

And in a similar vein, authors from CCPIT Patent and Trademark Law Office use practical knowledge to illustrate the evidence rights holders need to effectively protect their IP and win significant damages in China.

Likewise, Liu, Shen & Associates' article weighs up the pros and cons of pursuing both civil litigation and administrative action when seeking IP protection in China.

HFG Law & Intellectual Property's experts analyse how the applicability of trademarks has evolved amid the widespread use of original equipment manufacturers in China by overseas companies.

Meanwhile, DEQI Intellectual Property’s article clarifies some of the complexities surrounding divisional application strategies in China.

In addition, authors from AFD China Intellectual Property Law Office review China’s recent high-level decisions on trademark ‘use’, with valuable lessons for infringement.

Finally, Kangxin Partners's article considers what patentees can do to prevent claims being declared invalid because their amendments go beyond the scope of the original application.

We hope you enjoy reading our expert commentary on all the important issues shaping China’s IP environment in 2023.

Click here to read all the chapters from Managing IP's China Special Focus 2023.

more from across site and SHARED ros bottom lb

More from across our site

Erise IP has added a seven-practitioner trademark team from Hovey Williams, signalling its intention to help clients at all stages of development
News of prison sentences for ex-Samsung executives for trade secrets violation and an opposition filed by Taylor Swift were also among the top talking points
A multijurisdictional claim filed by InterDigital and a new spin-off firm in Germany were also among the top talking points
Duarte Lima, MD of Spruson & Ferguson’s Asia practice, says practitioners must adapt to process changes within IP systems, as well as be mindful of the implications of tech on their practices
Practitioners say the UK Supreme Court’s decision could boost the attractiveness of the UK for AI companies
New awards, including US ‘Firm of the Year’ and Latin America ‘Firm to Watch’, are among more than 90 prizes that will recognise firms and practitioners
DWF helped client Dairy UK secure a major victory at the UK Supreme Court
Hepworth Browne led Emotional Perception AI to victory at the UK Supreme Court, which rejected a previous appellate decision that said an AI network was not patentable
James Hill, general counsel at Norwich City FC, reveals how he balances fan engagement with brand enforcement, and when he calls on IP firms for advice
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in inventive step analyses
Gift this article